In this study, we utilized public scRNA-seq data to make a comprehensive analysis of the molecular characteristics, biological pathways, and transcription factor (TF) regulatory network of melanoma in an attempt to explore the prognosis and the impact of ICI therapy on each malignant subset and screen subsets that may contribute to the poor prognosis and resistance to immune therapy. Here, TF is linked to melanoma.